Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Similar articles for PubMed (Select 22583782)

1.

Antibiotic strategy in severe community-acquired pneumococcal pneumonia.

Le Bris-Tomczak A, Bedos JP, Billon C, Samdjee F, Le Monnier A.

Med Mal Infect. 2012 May;42(5):226-34. doi: 10.1016/j.medmal.2012.04.001. Epub 2012 May 12.

PMID:
22583782
2.

[Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].

Roger PM, Risso K, Hyvernat H, Landraud L, Vassallo M, Dellamonica J, de Salvador F, Cua E, Bernardin G.

Med Mal Infect. 2010 Jun;40(6):347-51. doi: 10.1016/j.medmal.2010.01.005. Epub 2010 Feb 20. French.

PMID:
20172672
3.

[Guidelines for treatment of pneumonia in intensive care units].

Emmi V.

Infez Med. 2005;Suppl:7-17. Review. Italian.

PMID:
16801748
4.

Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia.

Falguera M, Ruiz-González A, Schoenenberger JA, Touzón C, Gázquez I, Galindo C, Porcel JM.

Thorax. 2010 Feb;65(2):101-6. doi: 10.1136/thx.2009.118588. Epub 2009 Aug 23.

PMID:
19703825
5.

Guidelines for severe community-acquired pneumonia in the western world.

Vegelin AL, Bissumbhar P, Joore JC, Lammers JW, Hoepelman IM.

Neth J Med. 1999 Sep;55(3):110-7.

PMID:
10509069
6.

Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.

Lismond A, Carbonnelle S, Verhaegen J, Schatt P, De Bel A, Jordens P, Jacobs F, Dediste A, Verschuren F, Huang TD, Tulkens PM, Glupczynski Y, Van Bambeke F.

Int J Antimicrob Agents. 2012 Mar;39(3):208-16. doi: 10.1016/j.ijantimicag.2011.11.011. Epub 2012 Jan 14.

PMID:
22245497
7.

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Plouffe JF, Rakowsky A, Schuchat A, Whitney CG.

Arch Intern Med. 2000 May 22;160(10):1399-408.

PMID:
10826451
8.
9.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
10.

The efficacy of high-dose penicillin for community-acquired pneumonia diagnosed by pneumococcal urine antigen test.

Oka H, Ueda A, Watanuki Y, Tsukiji J, Kuroda H, Akashi S, Hirai Y, Fuyuki T, Kaneko T, Ishigatsubo Y.

J Infect Chemother. 2009 Apr;15(2):108-12. doi: 10.1007/s10156-009-0672-1. Epub 2009 Apr 25.

PMID:
19396521
11.

A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.

Jover F, Cuadrado JM, Andreu L, Martínez S, Cañizares R, de la Tabla VO, Martin C, Roig P, Merino J.

Eur J Intern Med. 2008 Jan;19(1):15-21. doi: 10.1016/j.ejim.2007.03.015. Epub 2007 Sep 19.

PMID:
18206596
12.

Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy.

Guchev IA, Yu VL, Sinopalnikov A, Klochkov OI, Kozlov RS, Stratchounski LS.

Clin Infect Dis. 2005 Jun 1;40(11):1608-16. Epub 2005 May 2. Erratum in: Clin Infect Dis. 2005 Aug 15;41(4):580-1.

13.

Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia.

Naucler P, Darenberg J, Morfeldt E, Ortqvist A, Henriques Normark B.

Thorax. 2013 Jun;68(6):571-9. doi: 10.1136/thoraxjnl-2012-203106. Epub 2013 Feb 26.

PMID:
23442364
14.

Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.

Reechaipichitkul W, Assawasanti K, Chaimanee P.

Southeast Asian J Trop Med Public Health. 2006 Mar;37(2):320-6.

PMID:
17124993
16.

Risk factors for drug-resistant Streptococcus pneumoniae and antibiotic prescribing practices in outpatient community-acquired pneumonia.

Jenkins TC, Sakai J, Knepper BC, Swartwood CJ, Haukoos JS, Long JA, Price CS, Burman WJ.

Acad Emerg Med. 2012 Jun;19(6):703-6. doi: 10.1111/j.1553-2712.2012.01365.x. Epub 2012 May 25.

PMID:
22632455
17.

Optimal therapy for severe pneumococcal community-acquired pneumonia.

Luján M, Gallego M, Rello J.

Intensive Care Med. 2006 Jul;32(7):971-80. Epub 2006 May 10. Review.

PMID:
16791660
18.

Evaluation of the Binax NOW Streptococcus pneumoniae urinary antigen assay in intensive care patients hospitalized for pneumonia.

Lasocki S, Scanvic A, Le Turdu F, Restoux A, Mentec H, Bleichner G, Sollet JP.

Intensive Care Med. 2006 Nov;32(11):1766-72. Epub 2006 Sep 7.

PMID:
16957905
19.

Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.

Yanagihara K, Izumikawa K, Higa F, Tateyama M, Tokimatsu I, Hiramatsu K, Fujita J, Kadota J, Kohno S.

Intern Med. 2009;48(7):527-35. Epub 2009 Apr 1.

20.

Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.

Ioachimescu OC, Ioachimescu AG, Iannini PB.

Int J Antimicrob Agents. 2004 Nov;24(5):485-90.

PMID:
15519482
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk